- Home
- KPLT vs ANTX Comparison
KPLT vs ANTX Comparison
Compare KPLT & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPLT
- ANTX
- Stock Information
- Founded
- KPLT 2012
- ANTX 2017
- Country
- KPLT United States
- ANTX United States
- Employees
- KPLT N/A
- ANTX N/A
- Industry
- KPLT Diversified Commercial Services
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- KPLT Consumer Discretionary
- ANTX Health Care
- Exchange
- KPLT Nasdaq
- ANTX Nasdaq
- Market Cap
- KPLT 34.5M
- ANTX 30.6M
- IPO Year
- KPLT N/A
- ANTX 2022
- Fundamental
- Price
- KPLT $15.52
- ANTX $1.12
- Analyst Decision
- KPLT Hold
- ANTX Buy
- Analyst Count
- KPLT 2
- ANTX 2
- Target Price
- KPLT $12.50
- ANTX $2.00
- AVG Volume (30 Days)
- KPLT 28.9K
- ANTX 104.9K
- Earning Date
- KPLT 08-13-2025
- ANTX 08-12-2025
- Dividend Yield
- KPLT N/A
- ANTX N/A
- EPS Growth
- KPLT N/A
- ANTX N/A
- EPS
- KPLT N/A
- ANTX N/A
- Revenue
- KPLT $267,101,999.00
- ANTX N/A
- Revenue This Year
- KPLT $22.26
- ANTX N/A
- Revenue Next Year
- KPLT $11.03
- ANTX N/A
- P/E Ratio
- KPLT N/A
- ANTX N/A
- Revenue Growth
- KPLT 13.04
- ANTX N/A
- 52 Week Low
- KPLT $5.08
- ANTX $0.96
- 52 Week High
- KPLT $15.87
- ANTX $1.68
- Technical
- Relative Strength Index (RSI)
- KPLT 77.92
- ANTX 56.45
- Support Level
- KPLT $11.20
- ANTX $1.03
- Resistance Level
- KPLT $14.55
- ANTX $1.17
- Average True Range (ATR)
- KPLT 1.01
- ANTX 0.04
- MACD
- KPLT 0.11
- ANTX 0.01
- Stochastic Oscillator
- KPLT 92.51
- ANTX 60.71
About KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.